Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lixte Biotechnology Holdings (LIXT) Other Working Capital Changes (2016)

Lixte Biotechnology Holdings' Other Working Capital Changes history spans 7 years, with the latest figure at -$21578.0 for Q4 2016.

  • For Q4 2016, Other Working Capital Changes changed N/A year-over-year to -$21578.0; the TTM value through Dec 2016 reached -$10930.0, changed N/A, while the annual FY2025 figure was -$40828.0, 153.97% down from the prior year.
  • Other Working Capital Changes reached -$21578.0 in Q4 2016 per LIXT's latest filing, down from $39970.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $43006.0 in Q4 2013 to a low of -$22546.0 in Q2 2016.
  • Average Other Working Capital Changes over 5 years is $12140.1, with a median of $10214.0 recorded in 2013.
  • Peak YoY movement for Other Working Capital Changes: soared 92.9% in 2015, then tumbled 1589.78% in 2016.
  • A 5-year view of Other Working Capital Changes shows it stood at $40179.0 in 2012, then rose by 7.04% to $43006.0 in 2013, then tumbled by 113.12% to -$5644.0 in 2014, then soared by 560.24% to $25976.0 in 2015, then plummeted by 183.07% to -$21578.0 in 2016.
  • Per Business Quant, the three most recent readings for LIXT's Other Working Capital Changes are -$21578.0 (Q4 2016), $39970.0 (Q3 2016), and -$22546.0 (Q2 2016).